The single biggest lever is the price per prescription, because the long-term bill is mostly volume multiplied by a high unit price that has not come down much. Before this work, the surge in these prescriptions was easy to see in headlines but hard to size at the national level, and easy to mistake for a cost borne mainly by the people taking them
Your care team reviews your labs, symptoms, and treatment response, provides coaching to improve outcomes, and offers guidance you can share with your prescribing clinician regarding dosing, tolerance, and long-term strategy.
There's simply no formal data exploring how these three specific compounds interactwhether they work together synergistically or potentially cancel each other out
However, the injection remains the only form currently approved for adolescents ages 12 years and older, which may influence insurance coverage decisions for families
Available at: Accessed 27 Nov 2022

Safety Concerns Documented risks include: Contamination risk with multiple pen entries Dosing errors more likely with complex regimens 55% of microdosers self-medicate without medical supervision Use of non-FDA approved compounded formulations 22% regret rate among microdosers Mathematical Modeling: What the Numbers Say Pharmacokinetic Simulations Recent mathematical models using real-world pharmacokinetic data reveal: *Theoretical efficacy based on area under curve (AUC) maintenance Key Modeling Insights Diminishing returns: Daily dosing provides minimal additional benefit over 3x weekly Efficacy threshold: Models suggest 75% efficacy retention even with daily microdosing Individual variation: Fast metabolizers may benefit more from split dosing Dose adjustment needed: Total weekly dose may need 10-20% increase with microdosing Open-source availability: Researchers have made pharmacokinetic models publicly available at GitHub (seanlawley/glp1) for those interested in exploring dosing optimization strategies
